NewYork-Presbyterian Hospital is the only tri-state-area hospital listed on the 2010 U.S.News & World Report "America's Best Children's Hospitals" "Honor Roll" and one of only eight children's hospitals in the nation to be ranked in all 10 clinical specialties. NewYork-Presbyterian provides children's health services at two major centers: NewYork-Presbyterian/Morgan Stanley Children's Hospital and the Phyllis and David Komansky Center for Children's Health.
NewYork-Presbyterian Hospital was recognized as a leader in all clinical specialties, including Cancer, Diabetes & Endocrinology, Gastroenterology, Heart & Heart Surgery, Kidney, Neonatology, Neurology & Neurosurgery, Orthopedics, Pulmonology and Urology.
The fourth annual "America's Best Children's Hospitals" rankings reflect reputation, volume and other patient-care-related factors. The full rankings can be viewed at www.usnews.com/childrenshospitals, and will be published in the August U.S. News "Best Hospitals" issue, available on newsstands July 27.
"At NewYork-Presbyterian Hospital, which includes Morgan Stanley Children's Hospital and the Komansky Center for Children's Health, caring for children means much more than providing the best-available medical care in all clinical specialty areas. Through our affiliation with two of the nation's leading medical colleges -- Weill Cornell Medical College and Columbia University College of Physicians and Surgeons -- our pediatric specialists are continually introducing new advanced treatment options," says Dr. Herbert Pardes, president and CEO of NewYork-Presbyterian Hospital. "At the same time, we strive to create a safe and comforting environment that fosters health and healing for our youngest patients and their families."
"We are proud to be counted again as one of the nation's leading children's hospitals, something that is only possible through the talent and dedication of all our employees and clinical staff," adds Dr. Steven J. Corwin, executive vice president and COO of NewYork-Presbyterian Hospital.
Multiomic signatures identified for rapid detection and treatment of high-risk T-ALL